Document is current
Any future updates will be listed below
-
Authors
Perlman, Kelly https://orcid.org/0000-0002-2716-0712
Chouinard-Watkins, Raphaël
Tanti, Arnaud
Cisbani, Giulia
Orri, Massimiliano https://orcid.org/0000-0003-1389-2610
Turecki, Gustavo https://orcid.org/0000-0003-4075-2736
Bazinet, Richard P.
Mechawar, Naguib https://orcid.org/0000-0003-4960-756X
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-156346)
Fonds de Recherche du Québec - Santé
Canada Research Chairs
- License Information
-
More Information
Article History
Received: 27 June 2021
Revised: 23 September 2021
Accepted: 1 October 2021
First Online: 18 October 2021
Competing interests
: RPB has received industrial grants, including those matched by the Canadian government, and/or travel support or consulting fees largely related to work on brain fatty acid metabolism from Arctic Nutrition, Bunge Ltd., DSM, Fonterra Inc, Mead Johnson, Natures Crops International, Nestec Inc. Pharmavite, and Sancero Inc. Moreover, Dr. Bazinet is on the executive of the International Society for the Study of Fatty Acids and Lipids and held a meeting on behalf of Fatty Acids and Cell Signaling, both of which rely on corporate sponsorship. Dr. Bazinet has given expert testimony in relation to supplements and the brain. The other authors declare no competing interest.
